How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Michael Schmidt, CFA, is a staff member of FINRA's Dispute Resolution Board with 20+ years of experience in the financial market. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive ...
How machine intelligence changes the rules of business by Marco Iansiti and Karim R. Lakhani In 2019, just five years after the Ant Financial Services Group was launched, the number of consumers using ...
Hosted on MSN
I got buzzed by a truck—then tested 12 bike radars. Here are the 5 I’d trust with my life
On a lunch-time ride in early June, a driver passed me entirely too close. I was riding on a road I’ve been on dozens of times, and my wheels were at the edge of the asphalt. Still, the truck passed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results